Forecast Bio, Inc.
PrivateLast Round
Seed Round
Aug 27, 2026
Total Funding Raised
$100,000
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Forecast Bio, Inc. is a biotechnology company developing an AI-powered preclinical platform that links cellular neurobiology to mental health outcomes.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Workflow Automation, ML Platforms, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Forecast Bio, Inc. Comparables
Compare Forecast Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eratos Therapeutics | 83% | |
| Mindstate Design Labs | 83% | |
| Neuroblox | 82% |
Forecast Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Aug 27, 2026 | ||||
| Accelerator | Mar 13, 2026 | ||||
| Accelerator | Feb 9, 2026 | ||||
| Seed | Jul 15, 2025 |
Forecast Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Consortium Québécois sur la découverte du médicament | Accelerator |
| One Mind | Accelerator |
| One Mind Accelerator | Seed |
| The Venture Collective | Accelerator |
| XEIA Venture Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2026
$2.4M raised in Seed Round.
- Mar 13, 2026
$100K raised from The Venture Collective and others.
Forecast Bio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Forecast Bio, Inc.'s valuation, stock price, and market status.
Is Forecast Bio, Inc. a public or private company?
Forecast Bio, Inc. is a private company.
What is the current stock price of Forecast Bio, Inc.?
Forecast Bio, Inc. is a private company with no public stock price. Caplight tracks Forecast Bio, Inc.'s secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Forecast Bio, Inc. worth (valuation)?
Valuation information for Forecast Bio, Inc. is not publicly available.
Can I buy Forecast Bio, Inc. stock?
Forecast Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Forecast Bio, Inc.'s last funding round?
Forecast Bio, Inc.'s most recent funding round was Accelerator on March 13, 2026.
Who are the main investors in Forecast Bio, Inc.?
Key investors in Forecast Bio, Inc. include One Mind.
Will Forecast Bio, Inc. IPO soon?
No public IPO plans have been announced for Forecast Bio, Inc..
How can I track Forecast Bio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Forecast Bio, Inc.'s secondary market activity and sign up for updates.